Browse Category

Stocks News 8 December 2025 - 9 December 2025

Strategy Inc (MSTR) Stock in December 2025: Massive Bitcoin Buy, Slashed Guidance and a High‑Risk 2026 Outlook

Strategy Inc (MSTR) Stock in December 2025: Massive Bitcoin Buy, Slashed Guidance and a High‑Risk 2026 Outlook

As of December 9, 2025, Strategy Inc (NASDAQ: MSTR), the former MicroStrategy, sits at the center of two storm systems: a brutally volatile Bitcoin market and rising scrutiny of its highly leveraged, crypto‑heavy business model. The stock trades around $181.67 per share, with intraday moves easily stretching several percentage points in either direction. Below is a deep dive into the…
CoreWeave (CRWV) Stock Today: Debt, AI Cloud Growth, and What the $2.25 Billion Convertible Notes Mean for 2026

CoreWeave (CRWV) Stock Today: Debt, AI Cloud Growth, and What the $2.25 Billion Convertible Notes Mean for 2026

CoreWeave, Inc. (NASDAQ: CRWV) has become one of the most closely watched AI infrastructure stocks of 2025. As of December 9, 2025, the Nvidia-backed “AI hyperscaler” is back in the spotlight after pricing an upsized $2.25 billion convertible senior notes offering, deepening investor debate over whether CoreWeave is a visionary AI cloud leader or a debt-fueled accident waiting to happen.…
iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025)

iBio (IBIO) Stock Jumps on Obesity Drug Momentum: All the Latest News, Analyst Targets and 2026–2027 Outlook (December 9, 2025)

As of December 9, 2025, iBio, Inc. (NASDAQ: IBIO) has turned into one of the louder tickers in the obesity‑drug corner of biotech. After closing Monday, December 8 at $1.67, up 39% on the day, IBIO is trading higher again in pre‑market action on Tuesday, with quotes between $1.76 and $1.81, pushing its market value to roughly $37–38 million. Benzinga…
Nvidia (NVDA) Stock Jumps as Trump Clears China AI Chip Sales – Latest Price, News and 2026–2030 Forecasts

Nvidia (NVDA) Stock Jumps as Trump Clears China AI Chip Sales – Latest Price, News and 2026–2030 Forecasts

Published: December 9, 2025 Key Takeaways Nvidia Stock Today: Price, Performance and Market Context As of around 12:53 UTC on Tuesday, December 9, 2025, Nvidia shares trade near $185.55, up about 1.7% on the day, according to real‑time quote data. Trefis notes the stock recently hit a high of about $207.04 in late October, meaning NVDA now sits roughly 10%…
AeroVironment (AVAV) Stock: $874M Army Deal, Q2 Earnings, and 2026 Price Targets on December 9, 2025

AeroVironment (AVAV) Stock: $874M Army Deal, Q2 Earnings, and 2026 Price Targets on December 9, 2025

Date: December 9, 2025 AeroVironment, Inc. (NASDAQ: AVAV), the U.S. defense-technology and drone specialist behind the Puma and Switchblade systems, heads into its fiscal Q2 2026 earnings report tonight with fresh contract wins, new software products, and a stock that is up sharply over the past year but still well below its 2025 peak. On December 9, 2025, AVAV trades…
Altimmune (ALT) Stock: CEO Shake-Up, Imminent MASH Data and 250% Upside Forecasts as of December 9, 2025

Altimmune (ALT) Stock: CEO Shake-Up, Imminent MASH Data and 250% Upside Forecasts as of December 9, 2025

Altimmune, Inc. (NASDAQ: ALT) has become a tightly wound biotech story heading into year‑end 2025. The small‑cap developer of liver and metabolic drugs is changing its CEO just weeks before a pivotal 48‑week readout in its lead MASH trial, while Wall Street models still point to triple‑digit upside from today’s share price. As of mid‑day on December 9, 2025, Altimmune…
Cheer Holding (CHR) Stock: Buyout Bids, Nasdaq Delisting Risk and Wild Penny-Stock Volatility as of December 9, 2025

Cheer Holding (CHR) Stock: Buyout Bids, Nasdaq Delisting Risk and Wild Penny-Stock Volatility as of December 9, 2025

Cheer Holding, Inc. (NASDAQ: CHR) has become one of the most dramatic micro-cap stories on the Nasdaq in late 2025. The Beijing-based AI and mobile internet company is simultaneously: For traders and investors tracking CHR on December 9, 2025, this is a classic “event-driven penny stock” story where corporate actions and listing status matter as much as fundamentals. Below is…
CSL Limited (ASX:CSL) Stock Outlook 2026: Is the Biotech Giant Finally a Buy After a 35% Sell-Off?

CSL Limited (ASX:CSL) Stock Outlook 2026: Is the Biotech Giant Finally a Buy After a 35% Sell-Off?

As of 9 December 2025 CSL Limited, long considered one of the most reliable growth names on the ASX, has just lived through one of the ugliest years in its listed history. After profit downgrades, a delayed spin-off, falling US vaccination rates and a shareholder revolt over executive pay, the stock is trading far below its early‑2025 highs. Yet underneath…
Palantir (PLTR) After-Hours on December 8, 2025: AI Deals, Insider Selling and Forecasts to Watch Before the December 9 Open

Palantir (PLTR) After-Hours on December 8, 2025: AI Deals, Insider Selling and Forecasts to Watch Before the December 9 Open

Palantir Technologies Inc. (NYSE: PLTR) ended Monday’s session with only a small price move, but under the surface the story is anything but quiet. After the bell on December 8, 2025, traders are weighing blockbuster AI growth, rich new partnerships, aggressive insider selling and sharply divided forecasts as they position for the December 9 market open. Below is a concise,…
Warby Parker (WRBY) Stock Soars on Google AI Glasses Timeline: Price Action, Earnings and 2026 Forecasts as of December 8, 2025

Warby Parker (WRBY) Stock Soars on Google AI Glasses Timeline: Price Action, Earnings and 2026 Forecasts as of December 8, 2025

Updated December 8, 2025 Warby Parker Inc. (NYSE: WRBY) is suddenly trading like an AI story, not just an eyewear retailer. Shares jumped around 15% on Monday, December 8, 2025, with the stock recently changing hands near $21.51, after fresh disclosures and media coverage confirmed that Google and Warby Parker plan to launch AI-powered smart glasses in 2026 as part…
Wave Life Sciences (WVE) Stock Explodes on Obesity Drug Breakthrough – What the New Data and Wall Street Forecasts Signal

Wave Life Sciences (WVE) Stock Explodes on Obesity Drug Breakthrough – What the New Data and Wall Street Forecasts Signal

Published: December 8, 2025 WVE stock more than doubles on massive volume Wave Life Sciences Ltd. (NASDAQ: WVE) staged a spectacular rally on Monday after unveiling positive interim data from its Phase 1 INLIGHT trial for obesity drug candidate WVE‑007. Shares surged from a close of $7.49 on Friday, December 5 to intraday levels around $17–18, a gain in the…
Rubrik (RBRK) Stock After Its Earnings Surge: Latest News, Analyst Targets and 2026 Outlook

Rubrik (RBRK) Stock After Its Earnings Surge: Latest News, Analyst Targets and 2026 Outlook

As of December 8, 2025, Rubrik, Inc. (NYSE: RBRK) sits squarely in the crosshairs of two of the hottest themes in markets: cybersecurity and artificial intelligence. Following a blowout fiscal Q3 2026 report on December 4 and a sharp rebound in the share price, fresh research notes, price-target hikes and new AI product announcements are reshaping the investment case for…
1 50 51 52 53 54 90

Stock Market Today

  • Stocks Rise on Easing Geopolitical Tensions, Strong US Economic Data
    January 22, 2026, 1:35 PM EST. U.S. stock indexes advanced on easing geopolitical tensions and robust economic data. The S&P 500, Dow Jones Industrials, and Nasdaq 100 gained between +0.56% and +0.72% amid relief over the Greenland sovereignty issue and NATO assurances. Strength in chipmakers, AI infrastructure, and major tech stocks supported the rally. Solid U.S. economic reports included initial unemployment claims at 200,000 (lower than expected), an upward Q3 GDP revision to 4.4%, and November personal spending up 0.5%. The Fed's preferred inflation metric, core PCE, rose 0.2% month-over-month, in line with forecasts. Natural gas prices surged over 12% to three-year highs due to Arctic cold forecasts, boosting energy stocks. Market watchers are focused on tariff developments, the Fed Chair nomination, and Q4 earnings which so far show strong results, with 81% of S&P 500 firms beating estimates.
Go toTop